NCT02701764View on ClinicalTrials.gov

Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 26, 2016

Primary Completion Date

December 1, 2018

Study Completion Date

December 1, 2018

Conditions
Dry Eye
Interventions
DRUG

Pregabalin

DRUG

Placebo

Trial Locations (1)

33133

Anat Galor, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT02701764 - Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis? | Biotech Hunter | Biotech Hunter